Radiation therapy for malignant pleural mesothelioma.

Area of Science:

• Thoracic Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Malignant pleural mesothelioma treatment with radiation presents technical difficulties.
• Conventional radiation therapy post-extrapleural pneumonectomy yielded acceptable outcomes historically.
• Intensity-modulated radiation therapy (IMRT) was introduced as a novel technique, but early use was associated with significant toxicity.

Purpose of the Study:

• To evaluate the safety and efficacy of modern radiation techniques in treating malignant pleural mesothelioma.
• To assess the evolving role of radiation therapy in the context of surgical interventions like extrapleural pneumonectomy (EPP) and pleurectomy.
• To address the findings of recent studies, such as SAKK 17/04, regarding the necessity of adjuvant radiation after EPP.

Main Methods:

• Review of institutional experiences with intensity-modulated radiation therapy (IMRT) in patients undergoing EPP or pleurectomy.
• Analysis of toxicity profiles associated with IMRT in this specific patient population.
• Consideration of data from clinical trials, including SAKK 17/04, examining the impact of adjuvant radiation post-EPP.

Main Results:

• Early IMRT implementation in malignant pleural mesothelioma cases showed concerning toxicity.
• With accumulated experience and refined techniques, IMRT can be safely administered post-EPP or pleurectomy.
• Recent clinical data, exemplified by SAKK 17/04, are prompting a re-evaluation of the routine use of radiation after EPP.

Conclusions:

• Intensity-modulated radiation therapy (IMRT) is becoming a safer option for malignant pleural mesothelioma patients when delivered by experienced centers.
• The optimal role and necessity of adjuvant radiation therapy following extrapleural pneumonectomy require further investigation, as suggested by recent trial outcomes.
• Balancing the benefits of radiation with its potential toxicities remains crucial in optimizing treatment strategies for malignant pleural mesothelioma.